Evidence map›Paper›PMID 33238488›Full record

ReviewMarine drugs2020

Carrageenan: Drug Delivery Systems and Other Biomedical Applications.

Edisson-Mauricio Pacheco-Quito, Roberto Ruiz-Caro, María-Dolores Veiga

Abstract readReview
In one paragraph

Review in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Carrageenan-Acyclovir Complex and Its Liposomal Form.International journal of molecular sciences · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Metabolomic characterization of algal nutraceuticals to elucidate their biological activities.Metabolomics : Official journal of the Metabolomic Society · 2025
    Review
  18. Review
  19. Article
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Edisson-Mauricio Pacheco-QuitoDepartment of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0002-6168-3218
Roberto Ruiz-CaroDepartment of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0001-9925-5051
María-Dolores VeigaDepartment of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.

Funding

Spanish Ministry of Economy, Industry and Competitiveness MAT2012-34552Spanish Research Agency and the European Regional Development Fund (AEI/FEDER, UE) MAT2016-76416-R
6 · The paper itself

Abstract

Marine resources are today a renewable source of various compounds, such as polysaccharides, that are used in the pharmaceutical, medical, cosmetic, and food fields. In recent years, considerable attention has been focused on carrageenan-based biomaterials due to their multifunctional qualities, including biodegradability, biocompatibility, and non-toxicity, in addition to bioactive attributes, such as their antiviral, antibacterial, antihyperlipidemic, anticoagulant, antioxidant, antitumor, and immunomodulating properties. They have been applied in pharmaceutical formulations as both their bioactive and physicochemical properties make them suitable biomaterials for drug delivery, and recently for the development of tissue engineering. This article provides a review of recent research on the various types of carrageenan-based biomedical and pharmaceutical applications.

Indexed as

Drug CarriersAnimalsAnti-Infective AgentsAntineoplastic AgentsAntioxidantsCarrageenanDrug CompoundingHematologic AgentsHumansHypolipidemic AgentsImmunologic FactorsMolecular StructureStructure-Activity RelationshipAnti-Infective AgentsAntineoplastic AgentsAntioxidantsCarrageenanDrug CarriersHematologic AgentsHypolipidemic AgentsImmunologic Factorsbiological activitycarrageenandrug deliverymarine polysaccharide

Identifiers

PMID33238488
PMCPMC7700686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.